Concord Wealth Partners boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 34.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 18,355 shares of the biopharmaceutical company’s stock after purchasing an additional 4,684 shares during the period. Concord Wealth Partners’ holdings in Gilead […]
Maxim Group Trims Gilead Sciences (NASDAQ:GILD) Target Price to $85 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Mission Wealth Management LP trimmed its holdings in shares of JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI – Free Report) by 21.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,375 shares of the company’s stock after selling 7,852 […]
Gilead Sciences (NASDAQ:GILD – Free Report) had its target price lowered by Royal Bank of Canada from $76.00 to $74.00 in a research note issued to investors on Friday morning, Benzinga reports. The brokerage currently has a sector perform rating on the biopharmaceutical company’s stock. A number of other research analysts also recently issued reports […]
Stegent Equity Advisors Inc. cut its stake in JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI – Free Report) by 17.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,840 shares of the company’s stock after selling 6,631 shares during the period. JPMorgan […]